Las Vegas, NVNCT07209111Now EnrollingIRB Ready

Neoplasm Malignant Clinical Trial in Las Vegas, NV

Access cutting-edge neoplasm malignant treatment through this clinical trial at a research site in Las Vegas. Study-provided care at no cost to qualified participants.

Sponsored by Merck Sharp & Dohme LLC

Quick Self-Assessment

See if you qualify for this Las Vegas location

Preparing your pre-screening questions…

Expert Care in Las Vegas

Access neoplasm malignant specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related neoplasm malignant treatment provided free

Apply for This Las Vegas Location

Check if you qualify for this neoplasm malignant clinical trial in Las Vegas, NV

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Las Vegas

    Convenient for NV residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Las Vegas site if eligible
  4. 4Begin participation

About This Neoplasm Malignant Study in Las Vegas

Researchers want to learn if calderasib given alone or with cetuximab can treat certain advanced solid tumors in people with the KRAS G12C mutation. The goals of this study are to learn: * How many people have the cancer respond (get smaller or go away) to calderasib alone or with cetuximab and how these responses compare * About the safety of calderasib alone or with cetuximab and if people tolerate the treatments.

Sponsor: Merck Sharp & Dohme LLC

Who Can Participate

Inclusion Criteria

The main inclusion criteria include but are not limited to the following:
Has locally advanced unresectable or metastatic solid tumor malignancy other than colorectal cancer and has progressed on, or following, standard of care systemic treatment
Has a tumor that demonstrates the presence of Kirsten rat sarcoma (KRAS) G12C mutation

Exclusion Criteria

The main exclusion criteria include but are not limited to the following:
Has uncontrolled, significant cardiovascular disease or cerebrovascular disease
Has known additional malignancy that is progressing or has required active treatment within the past 3 years
Has known active central nervous system metastases and/or carcinomatous meningitis and/or primary brain tumors
Has active infection, other than those permitted per protocol, requiring systemic therapy
Has not adequately recovered from major surgery or has ongoing surgical complications

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Las Vegas?

Yes, this clinical trial (NCT07209111) has an active research site in Las Vegas, NV that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Neoplasm Malignant Treatment Options in Las Vegas, NV

If you're searching for neoplasm malignant treatment options in Las Vegas, NV, this clinical trial (NCT07209111) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Las Vegas research site is actively enrolling participants for this clinical trial. You'll receive care from experienced neoplasm malignant specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all neoplasm malignant clinical trials near you to find additional studies recruiting in your area.

More Ankylosing Spondylitis Trials in Las Vegas, NV

See all ankylosing spondylitis clinical trials recruiting in Las Vegas — not just this study.

Browse Ankylosing Spondylitis Trials in Las Vegas

Ready to Join in Las Vegas?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Las Vegas, NV